HOME
ABOUT
LOG-IN
SEARCH BY
Search Results
Search Terms:Company Category= Life Sciences Company-Diagnostics| ANP Technologies, Inc. 824 Interchange Boulevard Newark, DE 19711 302-283-1730 Theresa Simonson info@anptinc.com www.anptinc.com ANP Technologies is a nano-biotechnology company focused on the detection/diagnostics market. We market bio-hazards detection products to the first-responder market. In the near future we will roll out products to address women's health issues (pregnancy and ovulation) and infectious diseases. We also have demonstrated superiority in sensitivity on drugs-of-abuse testing and will seek regulatory approvals to market products in this field. |
| Aptagen, LLC 250 North Main Street Jacobus, PA 17407 717-278-2436 G. Thomas Caltagirone, Ph.D. mailbox@aptagen.com www.aptagen.com Aptagen, LLC is a biotechnology company offering aptamer and aptabody custom-based services to replace antibodies in research, diagnostic platforms, drug discovery and therapeutics. |
| Beijing Med-Pharm Corp. 600 West Germantown Pike Suite 400 Plymouth Meeting, PA 19462 610-940-1675 F. Powell, CFO bd@beijingmedpharm.com www.beijingmedpharm.com BMP (a US public company) is a pharmaceutical marketing and distribution company in China that offers pre-market entry analysis, clinical trial management, product registration, market research, pharmaceutical distribution to hospitals, and pharmaceutical marketing to physicians, hospitals, and other healthcare providers. |
| Cira Discovery Sciences, Inc. 3701 Market Street Suite 340 Philadelphia, PA 19104-5505 215-966-6131 Wade Rogers, President & CEO info@ciradiscovery.com www.ciradiscovery.com Cira discovers and develops biomarkers for medical diagnostics and drug discovery/development. The company develops and applies novel computational tools in high-dimensional biology primarily for the purpose of discovering multiplex markers, which are believed to be more informative than individual markers. The company validates its computational tools by targeted fee-for-service applications. Clients include universities, government, and industry. |
| Delta Scientific, Inc. 1979 Stout Drive Building 5 Ivyland, PA 18974 215-443-5166 Janet Collem jcollem@deltasci.com www.deltasci.com Delta Scientific provides general lab equipment, reagents and supplies. Delta carries a full line of diagnostic analyzers and instruments. |
| Frontage Laboratories, Inc. 105 Great Valley Parkway Malvern, PA 19355 610-232-0100 Ron Connolly rconnolly@frontagelab.com www.frontagelab.com Frontage Laboratories is a leading pharmaceutical development company delivering high-quality research services to support pharmaceutical discovery, development and commercialization for large and emerging companies. We assist our partners in resolving complex product development issues through our combined experience in pharmaceutical analysis, bioanalytical testing and method development, and custom synthesis of investigational compounds. Fully compliant with cGMP/GLP regulations, we offer quality services, rapid turnaround and competitive pricing. |
| Fujirebio Diagnostics, Inc. 201 Great Valley Parkway Malvern, PA 19355 610-240-3800 Jenni Magrowski magrowskij@fdi.com www.fdi.com Fujirebio Diagnostics, Inc. is a premier diagnostics company and the industry leader in biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and commercialization of in-vitro diagnostic products for the management of human disease states, with an emphasis in oncology. The company has a worldwide distribution network, which enables physicians and patients to access its diagnostic products. |
| Immunicon Corporation 3401 Masons Mill Road Suite 100 Huntingdon Valley, PA 19006 215-830-0777 Byron D. Hewett, President and CEO BHewett@Immunicon.com www.immunicon.com Immunicon is developing and commercializing diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer. Our instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells in cancer patients or circulating endothelial cells, which are elevated in a variety of diseases. |
| Inteprod LLC 970-200 Rittenhouse Road Eagleville, PA 19403 610-650-9002 Lori Pegon inteprodinfo@inteprod.com www.inteprod.com Inteprod is a full-service supplier of comprehensive design, development, contract manufacturing, and assembly services for the medical, food safety, and pathogen detection industries. Inteprod’s deep expertise and capabilities in developing and manufacturing medical and food safety products include: handheld devices; point of care diagnostics; bedside diagnostics; LOC technology; patient monitoring; analytical instruments; minimally invasive surgical instruments; and pathogen detection diagnostics. |
| MicroMRI, Inc. 1429 Walnut Street Suite 1102 Philadelphia, PA 19102 215-564-1002 Maura Hannigan-Pierce mpierce@micromri.com www.MicroMRI.com MicroMRI specializes in commercializing highly-accurate, non-invasive biomarkers derived from next-generation imaging technology for debilitating diseases such as osteoporosis and osteoarthritis. MicroMRI then works with the medical community to validate and legitimize the biomarkers as surrogate endpoints for drug research, clinical studies and therapeutic treatment. The company’s intends to build a portfolio of imaging-based surrogate endpoints. |
| NanoScan Imaging, LLC 2250 Berks Road Lansdale, PA 19446 215-699-1703 Don Skerrett, CEO DSkerrett@aol.com www.nanoscanimaging.com NanoScan Imaging is managing the clinical development of N1177, a nanoparticle diagnostic pharmaceutical expected to improve x-ray computed tomography (“CT”)’s ability to diagnose and manage various forms of cancer and cardiovascular disease. NSI plans to take N1177 through proof of concept clinical studies and then sell it to a strategic partner to complete its development and commercialization. |
| Nanoselect, Inc. 15 Innovation Way (DBI) Newark , DE 19711 302-355-5987 Sal Pace pace@nanselect-sensors.com www.nanoselect.com NanoSelect is a nanotechnology company focused on the development of Carbon Nanotubes technology for specialty materials and bio-sensing applications in the Biotechnology and Medical Diagnostics industry. The company comprises a talented group of chemists, physicists and engineers dedicated to the development of MEMS and NEMS technologies in the field of life sciences. |
| Neuro Diagnsotic Devices 3701 Market Street Philadelphia, PA 19104 215-966-6104 Fred Fritz ffritz@neurodx.com www.neurodx.com NeuroDx is a medical device company addressing important unmet needs in the neurosurgical market. Our lead product, ShuntCheck™, is FDA cleared and addresses the $200 million cerebrospinal fluid (CSF) flow monitoring market. ShuntCheck™ will be launched into the US market in Q4’07 and will be the only product capable of directly and non-invasively assessing CSF shunt function in hydrocephalus patients. |
| Parsortix, Inc. 1835 Market Street Suite 1100 Philadelphia, PA 19103 215-972-1671 Larissa Milne larissa.milne@parsortix.com Microfluidic cell sorting for use in subsequent biomedical applications. Core technology involves a "cartridge" roughly the size of a microscope slide to isolate rare cells from a mixed cell population, such as that of whole blood. Applications in diagnostics, therapeutics, research. |
| PhenoTech, Inc. 3624 Market Street 5E Philadelphia, PA 19104 610-761-7311 Guy Maestre maestre@phenotech.com www.phenotech.com PhenoTech is a privately held biotechnology company pioneering the discovery, development and commercialization of a highly innovative class of reagents for diagnostic use in blood banks. These products will improve blood transfusions by allowing physicians to match better the donors and patients blood types, thereby reducing potential negative transfusion reactions. Their use should also significantly reduce blood typing costs. |
| Russell Biotech, Inc. 634 Meadwobrook Drive Huntingdon Valley, PA 19006 215-914-1276 Thomas Russell trussell@russellbiotech.com www.russellbiotech.com Russell Biotech provides innovative solutions for biological separations based on proprietary technology. Applications include separation of cells, proteins and nucleic acids. Products are being developed for research, diagnostic and therapeutic markets. |
| Sensory Arts & Science 1001 W. Ninth Ave. Suite A King of Prussia, PA 19406 610-768-9300 Dave Davis info@sensoryarts.com www.sensoryarts.com Sensory Arts & Science is a biomedical device and technology company, developing innovative methods, devices, and enabling technologies that address some of the most critical diseases and conditions that affect human sensory function. We apply innovative thinking and advanced technology to aid in the prevention, early detection, better measurement, and rehabilitation of certain broad-based population health issues, diseases and conditions. |